Literature DB >> 26660458

[Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].

K Marquardt1, M Stubbe2, U Broschewitz2.   

Abstract

BACKGROUND: In view of the discussion on primary human papillomavirus (HPV) screening it was necessary to evaluate recent and reliable data from the current cytology-based screening program.
METHODS: Since the year 2004 all cases of cervical cancer must be reported to the Joint State Quality Control Commission in Mecklenburg-Western Pomerania, corrected and supplemented by data of the State Cancer Registry. The screening histories of all patients, age, tumor stages and histological tumor types were analyzed.
RESULTS: Over a 10-year period (2004-2013) 985 women with invasive cervical cancer and complete data were identified, of whom 573 patients (58 %) had not had a cervical smear within the past 5 years, an irregular screening history was found in 312 patients (32 %) and 100 patients (10 %) had cervical cancer despite regular participation. In women who did not participate in the screening program, tumor stages T1b and higher were found in 85 %. In the group of women with regular screening 53 % were diagnosed with microinvasive cancer and in 38 % of women with irregular screening. The age distribution showed a peak for cervical cancer in the age group of 40-54 years. Squamous cell carcinoma dominated and adenocarcinoma was found in 17 % which showed a tendency to increase over the investigation time period.
CONCLUSION: Most cervical cancers and the advanced stages were found in women who did not participate in the screening program.

Entities:  

Keywords:  Adenocarcinoma of the uterine cervix; Cancer screening; Cervical cancer; Cervical cytology; Screening failure

Mesh:

Year:  2016        PMID: 26660458     DOI: 10.1007/s00292-015-0120-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  8 in total

1.  Incidence trends of adenocarcinoma of the cervix in 13 European countries.

Authors:  Freddie Bray; Bendix Carstensen; Henrik Møller; Marco Zappa; Maja Primic Zakelj; Gill Lawrence; Matti Hakama; Elisabete Weiderpass
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-09       Impact factor: 4.254

2.  Routine audit of large-scale cervical cancer screening programs.

Authors:  Jack Cuzick
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

Review 3.  Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective.

Authors:  Annabelle Farnsworth
Journal:  Acta Cytol       Date:  2011-07-22       Impact factor: 2.319

4.  Cervical cytologic smear false negative fraction. Reduction in a small community hospital.

Authors:  S E Wang; M J Ritchie; B F Atkinson
Journal:  Acta Cytol       Date:  1997 Nov-Dec       Impact factor: 2.319

5.  Persistent carcinoma in cervical cancer screening: non-participation is the most significant cause.

Authors:  Katrin Marquardt; Heinz H Büttner; Ulf Broschewitz; Malte Barten; Volker Schneider
Journal:  Acta Cytol       Date:  2011-10-08       Impact factor: 2.319

6.  Willingness to participate in mammography screening: a randomized controlled questionnaire study of responses to two patient information leaflets with different factual content.

Authors:  Elisabeth Gummersbach; Jürgen in der Schmitten; Achim Mortsiefer; Heinz-Harald Abholz; Karl Wegscheider; Michael Pentzek
Journal:  Dtsch Arztebl Int       Date:  2015-01-30       Impact factor: 5.594

7.  [Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society for Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health].

Authors:  P Regitnig; H P Dinges; E Ropp; H Fladerer; F Moinfar; G Breitenecker
Journal:  Pathologe       Date:  2007-09       Impact factor: 1.011

8.  Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence.

Authors:  M Zappa; C B Visioli; S Ciatto; A Iossa; E Paci; P Sasieni
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

  8 in total
  3 in total

1.  [The new S3 guideline "Prevention of cervical carcinoma" : What is important for pathology?]

Authors:  D Schmidt
Journal:  Pathologe       Date:  2018-05       Impact factor: 1.011

Review 2.  [Screening for cervical and breast cancer].

Authors:  J Wilm; S Schüler-Toprak; O Ortmann
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

3.  The effect of Pap smear screening on cervical cancer stage among southern Thai women.

Authors:  Li Niu; Shama Virani; Surichai Bilheem; Hutcha Sriplung
Journal:  Sci Rep       Date:  2019-11-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.